COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment Read more
Oral GnRH antagonists have potential in female health beyond endometriosis pain and uterine fibroids Read more
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData Read more